Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Articles

Page 1 of 1

  1. Mycobacterium avium complex (MAC) is driving a global rise in pulmonary disease (MAC-PD) characterised by chronic infection, granulomatous inflammation and impaired respiratory function. Better animal models are ...

    Authors: Timothy David Shaw, Camron M. Pearce, Ha Lam, Ilham M. Alshiraihi, Taru Dutt, Andres Obregon-Henao, Marcella Henao-Tamayo, Mary Jackson and Mercedes Gonzalez-Juarrero
    Citation: Mycobacteria 2025 1:4
  2. Mycobacterium tuberculosis extracellular vesicles (MEV) have been described as having potent immunological activities that are both beneficial and harmful to the host. Key to understanding this conflicting inform...

    Authors: Joan M. Ryan, Kimberly Shelton, Monika Dzieciatkowska, Nicole Kruh-Garcia and Karen M. Dobos
    Citation: Mycobacteria 2025 1:3
  3. Non-tuberculous mycobacteria (NTM) are ubiquitous environmental bacteria that can cause a variety of infections in humans, particularly those with underlying lung diseases. These infections are increasing worl...

    Authors: Shahrzad Shahrokhi Nejad, Ibrahim Bahrami Mianrood, Farid Javandoust Gharehbagh, Lida Lotfollahi and Ilad Alavi Darazam
    Citation: Mycobacteria 2025 1:2